Curaleaf issues response to Aurora Cannabis PR

Curaleaf says its 8-K press-release filing is furnished under Item 8.01 and, per Instruction B.2, is not deemed filed or incorporated by reference.

Rhea-AI Filing Summary

Curaleaf Holdings, Inc. (CURLF) reports that on September 2, 2026 it issued a press release responding to Aurora Cannabis' latest press release. The press release is included as Exhibit 99.1. The information in this report, including Exhibit 99.1, is furnished under Form 8-K Item 8.01 and, under General Instruction B.2, is not deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference into other securities law filings unless specifically referenced.

Key Terms

General Instruction B.2 of Form 8-K, Section 18 of the Securities Exchange Act of 1934, written communications, Inline XBRL

4 terms

General Instruction B.2 of Form 8-K regulatory

"In accordance with General Instruction B.2 of Form 8-K, the information"

Section 18 of the Securities Exchange Act of 1934 regulatory

"shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act"

written communications regulatory

"x | Written communications .425)"

Inline XBRL technical

"Cover Page Interactive Data File (embedded within the Inline XBRL document)"

Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What event did Curaleaf Holdings, Inc. (CURLF) disclose on September 2, 2026?

Curaleaf disclosed that on September 2, 2026 it issued a press release responding to Aurora Cannabis' latest press release, and furnished that release as Exhibit 99.1 under Item 8.01 (Other Events).

How is the Curaleaf (CURLF) press release treated under the Exchange Act?

Curaleaf states that the information in this Form 8-K, including Exhibit 99.1, is furnished under General Instruction B.2 and is not deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to that section’s liability.

Will Curaleaf (CURLF) automatically incorporate this press release into other SEC filings?

No. Curaleaf specifies that this Form 8-K and Exhibit 99.1 will not be incorporated by reference into any registration statement or other Securities Act or Exchange Act document, except where expressly set forth by specific reference.

What exhibit did Curaleaf (CURLF) attach to this Form 8-K?

Curaleaf attached Exhibit 99.1, described as a press release dated September 2, 2026, and Exhibit 104, the Cover Page Interactive Data File embedded within the Inline XBRL document.

Who signed Curaleaf’s (CURLF) September 2, 2026 Form 8-K?

The report was signed on behalf of Curaleaf Holdings, Inc. by Peter Clateman, who is identified as the company’s Chief Legal Officer, dated September 2, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 01:17 PM EDT Accepted by SEC EDGAR 09/02/2026 - 01:15 PM EDT Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): September 2, 2026

CURALEAF HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

British Columbia, Canada (State or other jurisdiction of incorporation or organization)			333-249081 (Commission File Number)			98-1461045 (I.R.S. Employer Identification Number)
250 Harbor Drive, Third Floor, Stamford, Connecticut 06902
(Address of principal executive offices and zip code)
( 917 ) 717 - 5875
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)

___________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

x			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

On September 2, 2026, Curaleaf Holdings, Inc. issued a press release responding to Aurora Cannabis' latest press release, a copy of which is attached as Exhibit 99.1.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number						Description
99.1						Press release dated September 2, 2026
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

						CURALEAF HOLDINGS, INC.
						(Registrant)
Date:			September 2, 2026			By:			/s/ Peter Clateman
						Name:			Peter Clateman
						Title:			Chief Legal Officer